LM
Luc Marengere
Angel InvestorActiveMarengere oversees the establishment of the new Canadian operations and the North American investment strategy as well as deal sourcing and ...
Montreal, CanadaFounded 2014
11
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Luc Marengere.
Investment Thesis & Strategy
Luc Marengere, as an angel investor, likely invests in various stages and industries, focusing on deal sourcing and the North American market. He seeks to identify and support promising early-stage companies with high growth potential.
Investment Activity
Deals per year over the last 15 years
1
20050
20061
20071
20080
20091
20100
20111
20120
20131
20142
20150
20161
20171
20181
2019Portfolio Companies
Selected investments from their portfolio of 11 companies
E
Esperas Pharma
Biotech · Seed, 2019
A
AurKa Pharma
Biotech · Seed, 2018
A
AL-S Pharma
Biotech · Seed, 2017
A
Access Vascular
Healthcare · Series A, 2015
E
Emovi
Healthcare · Series A, 2015
A
Acer Therapeutics
Biotech · Series A, 2014
l
leon nanodrugs
Biotech · Seed, 2012
P
Panthera Dental inc
Healthcare · Growth, 2010
K
Kent Imaging
Healthcare · Series A, 2008
C
Centogene
Biotech · Growth, 2007
C
CoLucid Pharmaceuticals
Biotech · Series C+, 2005
Frequently Asked Questions
Luc Marengere focuses on Pre-seed, Seed stage investments.